Aprepitant/Fosaprepitant Dimeglumine and Eskalith-CR
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Eskalith-CR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: lithium
Brand name: Eskalith, Lithobid, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Eskalith-CR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Eskata
- Aprepitant/Fosaprepitant Dimeglumine-Esketamine
- Aprepitant/Fosaprepitant Dimeglumine-Esketamine Hydrochloride
- Aprepitant/Fosaprepitant Dimeglumine-Esketamine nasal
- Aprepitant/Fosaprepitant Dimeglumine-Eslicarbazepine
- Aprepitant/Fosaprepitant Dimeglumine-Eslicarbazepine Acetate
- Eskalith-CR-Apresazide
- Eskalith-CR-Apresoline
- Eskalith-CR-Apresoline Injection
- Eskalith-CR-Apri
- Eskalith-CR-Apriso
- Eskalith-CR-Aprizio Pak